SYRE Stock Analysis: Buy, Sell, or Hold?
SYRE - Spyre Therapeutics, Inc. Common Stock
$93.73
-4.01 (-4.10%)
▼
5d:
+5.62%
30d:
+24.84%
90d:
+82.75%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 04, 2026
21d
Get Alerted When SYRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called SYRE this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SYRE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SYRE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SYRE is currently trading at $93.73, which is considered extended relative to its 30-day fair value range of $75.99 to $93.27.
Technical Outlook: Technically, SYRE is in a strong uptrend. Immediate support is located at $84.81, while resistance sits at $99.34. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: SYRE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SYRE is in a strong uptrend. Immediate support is located at $84.81, while resistance sits at $99.34. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: SYRE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$75.99 -
$93.27
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.1%)
- NEUTRAL: Near Wall St target ($101.53)
Trading Range Analysis
30-Day Trading Range
$75.99 -
$93.27
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$84.81
Resistance Level
$99.34
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-29.96
Wall Street Target
$101.53
(+8.3%)
Earnings Growth (YoY)
-99.7%
Share & Embed Analysis
Last updated: July 13, 2026 6:01 PM ET
Data refreshes hourly during market hours. Next update: 7:01 PM
Data refreshes hourly during market hours. Next update: 7:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SYRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Cameron Turtle
SELL
15000 shares
2026-04-01
Scott L Burrows
SELL
7500 shares
2026-04-01
Sheldon Sloan
SELL
7958 shares
2026-04-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 62 BUY |
